Phase I to IV Clinical Trials

First-in-Man Studies

Ecron Acunova provides you with a 6-bed ICU to conduct first-in-man, dose escalation and drug interaction studies.
Proof of Concept and Early Phase Studies Ecron Acunova has in-house therapeutic specialists, access to luminary sites, and sophisticated facilities to conduct PK/PD studies on special population and patients. We are experienced in the use of biomarkers and imaging as end points. This establishes us as adequately suitable for conducting proof-of-concept studies. In addition, with capability and experience in early phase II studies, we have attracted many sponsors to do their proof-of-concept studies with Ecron Acunova.

Rescue Studies

Ecron Acunova has taken over responsibility for a considerable number of projects which had been started elsewhere and which have not met clients expectations. Ecron Acunova specifically offers:

• Immediate set-up of rescue model
• Intensive measures adequately chosen to push your project
• Large investigator pool to speed up recruitment
• Competent contact with investigators
• Shifting of trial to countries with known high recruitment rates, such as Central Eastern Europe (CEE) and India.

Phase III and Registration Studies

Ecron Acunova has extensive experience in conducting pivotal multinational phase III studies as well as phase IV studies for registration purposes in specific countries. Currently we are engaged in conducting over 50 such trials.

Peri-Approval Studies

Ecron Acunova shapes PAS studies to the needs of late stage research and performs national/multinational large scale studies with appropriate design.

Post Marketing Surveillance (PMS)

Ecron Acunova creates value by:

• Marketing-experienced consultants and sales professionals to assist in the planning of your projects.
• Quality standards that are based on our experience in clinical research.

For more information, please see our website.